Ticker
CERSCompany Name
CERUS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 2.83 | $ 55.43M | $ 156.9M |
3/31/2025 | 2.71 | $ 55.49M | $ 150.53M |
12/31/2024 | 2.57 | $ 56.15M | $ 144.02M |
9/30/2024 | 2.53 | $ 53.49M | $ 135.26M |
6/30/2024 | 2.73 | $ 49.51M | $ 135.19M |
3/31/2024 | 2.81 | $ 49.37M | $ 138.97M |
12/31/2023 | 2.74 | $ 52.65M | $ 144.3M |
9/30/2023 | 3.26 | $ 48.17M | $ 156.82M |
6/30/2023 | 2.9 | $ 50.82M | $ 147.17M |
3/31/2023 | 2.55 | $ 58.63M | $ 149.77M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Liabilities / Equity
(=) D/E
D/E for CERUS CORP is calculated as follows: Liabilities [ $ 104.12M ] / Equity [ $ 109.23M ]
(=) D/E [ 0.95 ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.03 |
average | 1.39 |
median | 0.98 |
std | 1.31 |